The research efforts of
McGowan Institute for Regenerative Medicine
affiliated faculty members Michel Modo, PhD (pictured top), associate professor in the Department of Radiology at the University of Pittsburgh with secondary appointments in the Department of Bioengineering and the Center for Neural Basis of Cognition, and Stephen Badylak, DVM, PhD, MD (pictured bottom), a deputy director of the McGowan Institute, professor in the Department of Surgery, and director of the Center for Pre-Clinical Tissue Engineering within the Institute, were recently published in the journal, Biomaterials
is entitled “Diamagnetic chemical exchange saturation transfer (diaCEST) affords magnetic resonance imaging of extracellular matrix hydrogel implantation in a rat model of stroke.” This study was funded by a seed grant from the Department of Health of the Commonwealth of Pennsylvania (4100068505) and the National Institute for Neurological Disease and Stroke (R01NS08226).
The paper abstract reads:
Extracellular matrix (ECM) is widely used as an inductive biological scaffold to repair soft tissue after injury by promoting functional site-appropriate remodeling of the implanted material. However, there is a lack of non-invasive analysis methods to monitor the remodeling characteristics of the ECM material after implantation and its biodegradation over time. We describe the use of diamagnetic chemical exchange saturation transfer (CEST) magnetic resonance imaging to monitor the distribution of an ECM hydrogel after intracerebral implantation into a stroke cavity. In vitro imaging indicated a robust concentration-dependent detection of the ECM precursor and hydrogel at 1.8 and 3.6 ppm, which broadly corresponded to chondroitin sulfate and fibronectin. This detection was robust to changes in pH and improved at 37°C. In vivo implantation of ECM hydrogel into the stroke cavity in a rat model corresponded macroscopically to the distribution of biomaterial as indicated by histology, but mismatches were also evident. Indeed, CEST imaging detected an endogenous “increased deposition.” To account for this endogenous activity, pre-implantation images were subtracted from post-implantation images to yield a selective visualization of hydrogel distribution in the stroke cavity and its evolution over 7 days. The CEST detection of ECM returned to baseline within 3 days due to a decrease in fibronectin and chondroitin sulfate in the hydrogel. The distribution of ECM hydrogel within the stroke cavity is hence feasible in vivo, but further advances are required to warrant a selective long-term monitoring in the context of biodegradation.
Illustration: McGowan Institute for Regenerative Medicine.
Bio: Dr. Michel Modo
Bio: Dr. Stephen Badylak